Adam Morgan - Director at HERON THERAPEUTICS, INC. /DE/

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
HRTX on Nasdaq
All Insider Reports
All Insider Reports

Adam Morgan - trading volume in the past year for HERON THERAPEUTICS, INC. /DE/

Holdings reported by Adam Morgan for HERON THERAPEUTICS, INC. /DE/

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 8,753,290 $11,379,277 $1.30 30 Jan 2026 By Velan Capital Master Fund LP
Common Stock 123,737 $160,858 $1.30 30 Jan 2026 Direct
Stock Option (Right to Buy) 35,900 $62,107 $1.73 31 Jan 2025 Direct Common Stock
Series A Convertible Preferred Stock 70,012 08 Aug 2025 By Velan Capital Master Fund LP Common Stock

Transactions reported by Adam Morgan for HERON THERAPEUTICS, INC. /DE/

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.